Chubb Limited (CB)
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-11-04
$374.17+2.08%
Close 2026-11-04 · 1-day change
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-11-04
Research Workspace
Put CB beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Property & Casualty Insurance is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 6% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on earnings delivery, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskMostly healthy — no soft spokes
Chubb's disciplined underwriting drives strong performance. Revenue growth is slowing, though profits keep beating. Q3 revenue rose 3.9% year over year. The latest quarter beat estimates by 17.3%. The stock trades at 1.9x book value. Peers trade at a 1.8x median. Expectations look modest versus our view. A $30 million legal verdict threatens earnings. Peer multiples imply a price about 6% below where it trades. This read is provisional.
Trailing returns as of 2026-11-04. CB is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 25 analysts currently covering CB (as of Nov 2026).
Based on 11 Wall Street analysts offering 12-month price targets for CB in the last 4 months.
Continue this research
Compare CB with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CB Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Property & Casualty Insurance — fair value, gap to price, and forward P/E.
Compare the value case
Put CB next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Capital allocation via debt issuance and shareholder returns
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $374.17
The last 12 months of price, then the range of analyst 12-month targets from today’s $374.17.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Expected USI sale gain supports tangible book value growth and shareholder capital allocation.
Advances: Achieve strong growth in operating earnings and EPS
Earnings beat alongside premium growth supports operating growth, though the headline alone gives limited detail.
Advances: Sustain disciplined underwriting with strong combined ratios
Strong underwriting income and a profit beat support disciplined underwriting and earnings objectives.
Legal verdict could impact financial stability and earnings growth.
Advances: Grow life insurance premiums and segment income
Life business growth aligns with premium and income objectives.
Advances: Achieve strong growth in operating earnings
Earnings beat supports growth in operating earnings objective.
Advances: Achieve strong growth in operating earnings
Strong Q2 results support growth in operating earnings.
Advances: Achieve strong growth in operating earnings
Higher profit supports strong growth in operating earnings.
